Download PDF
Zentralbl Gynakol 2004; 126(1): 14-18
DOI: 10.1055/s-2004-820530
Übersicht

© Georg Thieme Verlag Stuttgart · New York

Schwangerschaft nach Mammakarzinom

Pregnancy After Treatment of Breast CancerT. Strowitzki1
  • 1Abt. Gynäkologische Endokrinologie und Fertilitätsstörungen, Frauenklinik, Universitätsklinikum Heidelberg
Further Information

Publication History

Publication Date:
24 February 2004 (online)

    Permissions and Reprints

Zusammenfassung

Die Frage einer Schwangerschaft nach Mammakarzinom stellt sich zunehmend häufig. Chemotherapie insbesondere mit Alkylantien wirkt sich negativ auf die konsekutive Fertilität aus. In überwiegend retrospektiven Studien kann kein nachteiliger Effekt einer Schwangerschaft für die Prognose ermittelt werden. Das relative Risiko bez. Überleben bei Schwangerschaft nach Mammakarzinom liegt zwischen 0,2 und 0,8. Ein kurzes Intervall von weniger als 6 Monaten nach Mammakarzinom könnte die Prognose negativ beeinflussen. Der Nodalstatus scheint ohne Einfluss zu sein. Ein „healthy mother”-Effekt könnte in erheblichem Maße zu einer Bias der Studienergebnisse beitragen. Für eine hormonelle Stimulation zur Sterilitätstherapie nach Mammakarzinom ist die Studienlage unzureichend, so dass hier keine valide Empfehlung gegeben werden kann.

Abstract

The number of patients asking for pregnancy after being treated for breast cancer is steadily increasing. Chemotherapy, in particular alkylants, might impair fertility. The prognosis of breast cancer is not negatively affected by a consecutive pregnancy as shown in retrospective studies. The relative risk concerning survival is reduced to 0.2-0.8 by pregnancy. However, a short interval of less than 6 months after breast cancer treatment could have a negative effect. The nodal status is without significance. Study results could be severely biased by a socalled “healthy mother” effect. There is no sufficient data to allow any conclusions on the effect of hormonal stimulation for infertility treatment in breast cancer patients.

Schlüsselwörter

Mammakarzinom - Schwangerschaft - Prognose

Key words

Breast cancer - pregnancy - prognosis

Literatur

  • 1 Bines J, Oleske D M, Cobleigh M A. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.  J Clin Oncol. 1996;  14 1718-1729
    PubMedGoogle Scholar
  • 2 Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe J M. Fertility after treatment for Hodgkin's disease.  Ann Oncol. 2002;  13 Suppl 1 138-147
    CrossrefPubMedGoogle Scholar
  • 3 Boostanfar R, Jain J K, Mishell D R, Paulson R J. A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction.  Fertil Steril. 2001;  75 1024-1026
    CrossrefPubMedGoogle Scholar
  • 4 Botelho F, Clark D A. How might pregnancy immunize against breast cancer?.  Am J Reprod Immunol. 1998;  39 279-283
    PubMedGoogle Scholar
  • 5 Brown J R, Modell E, Obasaju M, King Y K. Natural cycle in-vitro fertilization with embryo cryopreservation prior to chemotherapy for carcinoma of the breast.  Hum Reprod. 1996;  11 197-199
    PubMedGoogle Scholar
  • 6 Clark R M, Chua T. Breast cancer and pregnancy: the ultimate challenge.  Clin Oncol (R Coll Radiol). 1989;  1 11-18
    CrossrefPubMedGoogle Scholar
  • 7 Cooper D R, Butterfield J. Pregnancy subsequent to mastectomy for cancer of the breast.  Ann Surg. 1970;  171 429-433
    PubMedGoogle Scholar
  • 8 Dow K H, Harris J R, Roy C. Pregnancy after breast-conserving surgery and radiation therapy for breast cancer.  J Natl Cancer Inst Monogr. 1994;  16 131-137
    PubMedGoogle Scholar
  • 9 El Hussein E, Tan S L. Successful in vitro fertilization and embryo transfer after treatment of invasive carcinoma of the breast.  Fertil Steril. 1992;  58 194-196
    PubMedGoogle Scholar
  • 10 Gelber S, Coates A S, Goldhirsch A, Castiglione-Gertsch M, Marini G, Lindtner J, Edelmann D Z, Gudgeon A, Harvey V, Gelber R D. International Breast Cancer Study Group . Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer.  J Clin Oncol. 2001;  19 1671-1675
    PubMedGoogle Scholar
  • 11 Ginsburg E S, Yanushpolsky E H, Jackson K V. In vitro fertilization for cancer patients and survivors.  Fertil Steril. 2001;  75 705-710
    CrossrefPubMedGoogle Scholar
  • 12 Goldhirsch A, Gelber R D, Castiglione M. The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group.  Ann Oncol. 1990;  1 183-188
    PubMedGoogle Scholar
  • 13 Hankey B F, Miller B, Curtis R, Kosary C. Trends in breast cancer in younger women in contrast to older women.  J Natl Cancer Inst Monogr. 1994;  16 7-14
    PubMedGoogle Scholar
  • 14 Harvey J C, Rosen P P, Ashikari R, Robbins G F, Kinne D W. The effect of pregnancy on the prognosis of carcinoma of the breast following radical mastectomy.  Surg Gynecol Obstet. 1981;  53 723-725
    PubMedGoogle Scholar
  • 15 Koyama H, Wada T, Nishizawa Y, Iwanaga T, Aoki Y. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer.  Cancer. 1977;  39 1403-1409
    CrossrefPubMedGoogle Scholar
  • 16 Kroman N, Jensen M B, Melbye M, Wohlfahrt J, Mouridsen H AT. Should women be advised against pregnancy after breast-cancer treatment?.  Lancet. 1997;  350 319-322
    CrossrefPubMedGoogle Scholar
  • 17 Lethaby A E, O'Neill M A, Mason B H, Holdaway I M, Harvey V J. Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group.  Int J Cancer. 1996;  67 751-755
    CrossrefPubMedGoogle Scholar
  • 18 Levine M N, Bramwell V H, Pritchard K I, Norris B D, Shepherd L E, Abu-Zahra H, Findlay B, Warr D, Bowman D, Myles J, Arnold A, Vandenberg T, MacKenzie R, Robert J, Ottaway J, Burnell M, Williams C K, Tu D. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.  J Clin Oncol. 1998;  16 2651-2658
    CrossrefPubMedGoogle Scholar
  • 19 Malamos N A, Stathopoulos G P, Keramopoulos A, Papadiamantis J, Vassilaros S. Pregnancy and offspring after the appearance of breast cancer.  Oncology.. 1996;  53 471-475
    PubMedGoogle Scholar
  • 20 Meurer L N, Lena S. Cancer recurrence and mortality in women using hormone replacement therapy: meta-analysis.  J Fam Pract. 2002;  51 1056-1062
    PubMedGoogle Scholar
  • 21 Mignot L, Morvan F, Berdah J, Querleu D, Laurent J C, Verhaeghe M, Fontaine F, Marin J L, Gorins A, Marty M. Pregnancy after treated breast cancer.  Results of a case-control study Presse Med. 1986;  15 1961-1964
    PubMedGoogle Scholar
  • 22 Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen.  Hum Reprod. 2003;  18 90-95
    CrossrefPubMedGoogle Scholar
  • 23 Petrek J A. Pregnancy safety after breast cancer.  Cancer. 1994;  74 Suppl 1 528-531
    PubMedGoogle Scholar
  • 24 Recchia F, Sica G, De Filippis S, Saggio G, Rosselli M, Rea S. Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study.  Anticancer Drugs. 2002;  13 417-424
    CrossrefPubMedGoogle Scholar
  • 25 Reyno L M, Levine M N, Skingley P, Arnold A, Abu Zahra H. Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer.  Eur J Cancer. 1992;  29 A 21-23
    PubMedGoogle Scholar
  • 26 Sankila R, Heinavaara S, Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect”.  Am J Obstet Gynecol.. 1994;  170 818-823
    PubMedGoogle Scholar
  • 27 Schilsky R L, Lewis B J, Sherins R J, Young R C. Gonadal dysfunction in patients receiving chemotherapy for cancer.  Ann Intern Med. 1994;  16 125-129
    PubMedGoogle Scholar
  • 28 Surbone A, Petrek J A. Childbearing issues in breast carcinoma survivors.  Cancer. 1997;  79 1271-1278
    CrossrefPubMedGoogle Scholar
  • 29 Sutton R, Budzar A U, Hortobagyi G N. Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients.  Cancer. 1990;  65 847-850
    PubMedGoogle Scholar
  • 30 Upponi S S, Ahmad F, Whitaker I S, Purushotham A D. Pregnancy after breast cancer.  Eur J Cancer. 2003;  39 736-741
    CrossrefPubMedGoogle Scholar
  • 31 Velentgas P, Daling J R, Malone K E, Weiss N S, Williams M A, Self S G, Mueller B A. Pregnancy after breast carcinoma: outcomes and influence on mortality.  Cancer. 1999;  85 2424-2432
    CrossrefPubMedGoogle Scholar
  • 32 von Schoultz E, Johansson H, Wilking N, Rutqvist L E. Influence of prior and subsequent pregnancy on breast cancer prognosis.  J Clin Oncol. 1995;  13 430-434
    PubMedGoogle Scholar

Prof. Dr. med. Thomas Strowitzki

Abt. Gynäkologische Endokrinologie und Fertilitätsstörungen

Frauenklinik, Universitätsklinikum Heidelberg

Voßstr. 9

69115 Heidelberg

      >